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ABSTRACT
The circadian clock contributes to the timing of many body functions
including metabolism and reproduction. The hepatokine fibroblast
growth factor 21 (FGF21) is a critical metabolic regulator involved in
modulation of fertility. Here we show that lack of the clock component
REV-ERBα elevates FGF21 levels in liver and plasma. At the
molecular level, REV-ERBα modulates the expression of FGF21 via
the liver-specific hepatic nuclear factor 6 (HNF6). We conclude that
REV-ERBα regulates metabolism and reproduction, at least in part,
via regulation of Fgf21.
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INTRODUCTION
The circadian clock allows organisms to predict daily recurring
events such as sunrise, emergence of a particular food source and
presence of predators. This enables them to optimally time
physiological processes to the environment in order to enhance
survival. For the survival of the species, successful reproduction is
essential and factors enhancing the chance of reproductive success
are conserved. Since the circadian system not only synchronizes
physiology and behavior in an organism, but also is able to adapt to
environmental changes such as seasons, it is not surprising that de-
synchronization of the circadian system or mutation in clock genes
can affect reproductive capacity (Ikegami and Yoshimura, 2012;
Boden et al., 2013). Lack of the clock gene Bmal1 in mice leads to
irregular estrous cycles (Ratajczak et al., 2009) and impaired
ovulation (Boden et al., 2010) for which Bmal1 in ovarian theca
cells appears to be important (Mereness et al., 2015). Furthermore,
mice with a mutation in the Clock gene also display an irregular
estrous cycle (Kennaway et al., 2004; Miller et al., 2004), and Per1/
Per2 mutants develop irregular estrous cycles as they age (Pilorz
and Steinlechner, 2008). The nuclear receptor and clock
component REV-ERBα is expressed with a circadian rhythm and
represses Bmal1 (Preitner et al., 2002), encoding a positive
regulator of clock output genes. REV-ERBα also represses other
genes to regulate metabolism in a tissue-dependent manner (Cho
et al., 2012; Bugge et al., 2012). Hence, REV-ERBα is central to
regulate complex interactions between the circadian clock and
metabolism. Female mice lacking Rev-erbα display reduced
fertility while males appear to mate and reproduce normally
(Chomez et al., 2000).
Recent studies indicate that the reproductive axis and
metabolism are sensitive to fibroblast growth factor 21 (FGF21)
(Owen et al., 2013; Nies et al., 2016). FGF21 is a member of the
endocrine FGF subfamily that is a critical metabolic regulator
(Itoh, 2010; Reitman, 2007; Beenken and Mohammadi, 2009) and
over-expression of Fgf21 renders female mice infertile (Owen
et al., 2013; Inagaki et al., 2007). Because the Fgf21 promoter
contains nuclear receptor response elements and E-boxes (Estall
et al., 2009; Tong et al., 2010), we investigated whether Fgf21 is
regulated directly or indirectly by clock components. We find that
Fgf21 is regulated indirectly by the nuclear receptors REV-ERBα
via HNF6, and the clock protein PER2 modulates the repressive
function of REV-ERBα and/or the transcriptional efficiency of
PPARα-mediated expression of Fgf21. Thus, FGF21 may be an
intermediary between the clock components, metabolism and
reproductive fitness.
RESULTS
Rev-erbα knock-out mice display reduced fertility
Breeding of Rev-erbα−/− animals in our facility revealed reduced
fertility of these animals, with the average number of pups per
mating pair reduced in Rev-erbα−/− compared to the heterozygous
Rev-erbα+/− breeding pairs (Fig. 1A). Interestingly, also the number
of litters per mating period was reduced (Fig. 1B) indicating that
Rev-erbα−/− breeding pairs took longer to produce offspring
(Fig. 1C). This observation is consistent with a previous report
describing reduced reproduction in Rev-erbα knock-out mice
(Chomez et al., 2000).
Recent studies indicate that the reproductive axis is sensitive to
fibroblast growth factor 21 (FGF21) (Owen et al., 2013). The
phenotype displayed by Rev-erbα−/− mice is reminiscent of
animals overexpressing Fgf21 (Owen et al., 2013), therefore, we
tested whether Fgf21 expression is altered in Rev-erbα−/− mice.
We found that Fgf21 mRNA was diurnally expressed in the liver
of wild-type mice in a similar fashion as Bmal1 mRNA, a REV-
ERBα target gene (Preitner et al., 2002) and in an inverted diurnal
pattern compared to the E-box-driven Per1 gene (Preitner et al.,
2002) (Fig. 1D). Fgf21 mRNA expression was increased in Rev-
erbα−/− mice at all time points over the day compared to controls
(Fig. 1D). Similarly, FGF21 protein levels were also increased in
plasma of Rev-erbα−/− mice with pronounced elevation at
Zeitgeber time (ZT)12 and ZT18 (Fig. 1E), but plasma FGF21
levels were not diurnal in wild-type animals (Fig. 1E). Since
REV-ERBα is a nuclear receptor with repressive potential, we
tested whether REV-ERBα can directly regulate the Fgf21
promoter.Received 29 August 2016; Accepted 7 November 2016
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Fgf21 is regulated by REV-ERBα/HNF6 and PPARα/RXRα
Bioinformatic analysis of the Fgf21 promoter revealed the presence
of E-box elements to which the circadian clock factors BMAL1/
CLOCK bind as heterodimers. Furthermore, we identified REV-
ERBα binding sites, so-called putative retinoid orphan receptor
elements (ROREs) and PPARα binding sites (PPARE). In a first
step we tested activation of the Fgf21 promoter by BMAL1 and
CLOCK using a transactivation assay. A 3.1 kB-long fragment of
the Fgf21 promoter was linked to a luciferase reporter gene (Fgf21::
luc) and transfected into NIH 3T3 cells along with increasing
amounts of Bmal1 and Clock expression vectors (Fig. 2A). As
expected, BMAL1/CLOCK induced the Per1::luc control reporter
in a dose-dependent manner. In contrast, the Fgf21::luc reporter was
not induced, indicating that BMAL1 and CLOCK are not regulating
the Fgf21 promoter and hence are probably not directly responsible
for the diurnal expression of Fgf21 mRNA observed in
Fig. 1D. Since BMAL1 and CLOCK activate not only Rev-erbα
but also Pparα (Canaple et al., 2006), the expected repression of the
Fgf21::luc reporter is probably compensated by the activating
potential of PPARα (Inagaki et al., 2007).
We tested the repressive potential of REV-ERBα on the 3.1 kB
Fgf21 promoter, containing four ROREs and one PPARE,
designated as R1-R4 and P in Fig. 2C, respectively. REV-ERBα
repressed theBmal1::luc reporter as expected, and also repressed the
Fgf21::luc reporter (Fig. 2B) in a dose-dependent manner. Mutation
of the R1 element in the Fgf21::luc reporter reduced the repressive
potential of REV-ERBα (Fig. 2C), which is consistent with previous
findings that REV-ERBα may repress Fgf21 expression via this
RORE site (Estall et al., 2009). Interestingly, however, the repression
was not completely reversed by the mutation of R1, suggesting that
additional promoter elements are most likely involved in the REV-
ERBα-mediated repression of Fgf21. Therefore, we tested the R2
and R3 elements as potential REV-ERBα binding sites, but no
repression through these two sites was observed (Fig. 2C). In
contrast, the R4 element appeared to be involved in the repression of
Fgf21 by REV-ERBα, as mutation of this element partially
abolished the repressive potential of REV-ERBα (Fig. 2C).
Hence, the ROREs R1 and R4 may be the sites of REV-ERBα
binding at the Fgf21 promoter, regulating its expression. Since the
classical mechanism of REV-ERBα-mediated repression involves
competition with the transcriptional activator RORα, we tested
whether RORα activates the Fgf21::luc construct. As expected,
RORα could activate the Bmal1::luc reporter in a dose-dependent
manner (Fig. 2D), however, the Fgf21::luc reporter did not or only
poorly respond to RORα (Fig. 2D). Therefore, we suspected that
Fgf21 is indirectly regulated by REV-ERBα via hepatic nuclear
factor 6 (HNF6), a second mechanism through which REV-ERBα
can act (Zhang et al., 2015) (see also the presence of an HNF6
binding site H in Fig. 2C). Transactivation experiments in Hepa-
1c1c7 cells revealed that REV-ERBα suppresses the Bmal1::luc
reporter in an HNF6 independent manner, becauseHnf6 shRNA did
not affect this repression (Fig. 2E); although Hnf6 mRNA and
protein was strongly repressed with Rev-erbα expression unaffected
(Fig. S1). Interestingly, Hnf6 shRNA induced Fgf21 mRNA
expression, indicating that HNF6 is mediating a repressing activity
on the Fgf21 promoter (Fig. S1). Therefore, we tested the influence
of HNF6 on the REV-ERBα repressive function of the Fgf21
promoter observed in Fig. 2B. We found that Hnf6 shRNA, but not
scrambled shRNA, increased the luciferase activity in theFgf21::luc
reporter, suggesting that HNF6 is a direct modulator of this
promoter, and the lack of it increases baseline expression of
Fgf21. Accordingly, the repression by REV-ERBα on this promoter
only partially repressed activation and in absence of HNF6, REV-
ERBα alone did not repress the Fgf21::luc reporter below baseline
levels (Fig. 2E). This suggests that repression of the Fgf21 promoter
is most likely the result of cooperation between HNF6 and REV-
ERBα. Interestingly, there is an HNF6 binding site (Zhang et al.,
2015) close to the RORE designated as R1 in Fig. 2C. Mutating this
Fig. 1. Female Rev-erbα−/− mice display signs of
reduced fertility. (A) Rev-erbα−/− (red bar) mating pairs
produce significantly less pups per litter compared to
Rev-erbα+/− (black bar) pairs. Unpaired two-tailed t-test,
***P<0.0001, n=18 for Rev-erbα+/− and n=8 for Rev-
erbα−/−, F-test reveals no difference in variance,
F=2.41, DFn=17, Dfd=7. (B) Number of litters permating
period is reduced in Rev-erbα−/− (red bar) mating pairs
compared to Rev-erbα+/− (black bar) pairs. Unpaired
two-tailed t-test, ***P<0.0001, n=13 for Rev-erbα+/− and
n=8 for Rev-erbα−/−, F-test reveals difference in
variance, F=51.38, DFn=12, Dfd=7. (C) Inter-litter
period is significantly longer in Rev-erbα−/− (red bar)
compared to Rev-erbα+/− (black bar) mating pairs.
Unpaired two-tailed t-test, ***P<0.0001, n=16 for Rev-
erbα+/− and n=6 for Rev-erbα−/−, F-test reveals
difference in variance, F=8.793, DFn=5, Dfd=15.
(D) Hepatic Fgf21mRNA in the liver is increased in Rev-
erbα−/− (red line) compared to Rev-erbα+/+ mice (black
line). Two-way ANOVA with Bonferroni post-test. The
two curves are significantly different, P=0.0008, n=4.
(E) Plasma FGF21 protein levels are significantly
increased in Rev-erbα−/− (red line) compared to
Rev-erbα+/+ animals (black line). Two-way ANOVA with
Bonferroni post-test. The two curves are significantly
different, P=0.0003, n=4-6. All values are mean±s.e.m.
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HNF6 binding site abolishedREV-ERBαmediated repression of the
Fgf21::luc reporter (Fig. 2F), indicating that repression of this
reporter by REV-ERBα requires the binding of HNF6.
Becausewe identified a PPAR binding site (P in Fig. 2C) between
the RORE R1 and R2, we tested whether PPARα, together with its
heterodimerizing partner RXRα, may modulate the Fgf21::luc
reporter. We observed that PPARα activated this reporter and
combined with RXRα this induction was even greater (Fig. 2G).
Addition of Per2 increased this activation further (Fig. 2G),
indicating that PPARα, RXRα and Per2 have an activating
function on the Fgf21 promoter.
Binding of REV-ERBα, HNF6 andPPARα to theFgf21 promoter
in liver
In order to test whether the regulation of the Fgf21 promoter by
REV-ERBα, HNF6 and PPARα can occur in liver tissue, we
Fig. 2. Regulation of the Fgf21 promoter by clock
components. (A) Dose-dependent activation of the
Per1::luc promoter by BMAL1 and CLOCK (black
bars) and no BMAL1/CLOCK activation of the Fgf21::
luc reporter (white bars) in NIH3T3 cells (n=3).
(B) Dose dependent repression by REV-ERBα on the
Bmal1::luc reporter (black bars) and the Fgf21::luc
reporter (white bars) in NIH3T3 cells (n=4).
(C) Mutation analysis of the Fgf21 promoter. Top left:
schematic diagram showing the positions of the four
ROREs (R1-R4), the PPAR element (blue) and the
HNF6 binding site (green). Top right: diagram of the
mutations in R1 and R4, respectively. Bottom: panels
of fold change of the various constructs. Black bars:
reference value for the Bmal1::luc and Fgf21::luc
reporters, respectively. White bars: relative repression
by Rev-erbα. Hatched bars: reduced repression by
Rev-erbα on the mutated Fgf21::luc reporter (n=4).
(D) Dose-dependent activating potential of RORα on
the Bmal1::luc reporter (black bars) but not on the
Fgf21::luc reporter (white bars) in NIH3T3 cells (n=3).
(E) Repression of the Bmal1::luc (white bars) and
Fgf21::luc (blue bars) reporters in Hepa-1c1c7 cells
involves Hnf6. Sc shRNA, scrambled shRNA; Hnf6
shRNA, knockdown of Hnf6 (n=3). (F) Repressive
potential of REV-ERBα in Hepa-1c1c7 cells on the
Bmal1::luc, the Fgf21::luc and the Hnf6 site mutated
Fgf21::luc (mut Fgf21::luc) reporters (n=3). (G) Fold
induction of the Fgf21::luc reporter by Pparα, Rxrα
and Per2 in NIH3T3 cells (n=4). All panels: one-way
ANOVA with Bonferroni post-test. *P<0.05, **P<0.01,
***P<0.001, values are means±s.d.
3
RESEARCH ARTICLE Biology Open (2017) 6, 1-7 doi:10.1242/bio.021519
B
io
lo
g
y
O
p
en
performed chromatin immunoprecipitation (ChIP) experiments.
Chromatin from livers of female mice was isolated and antibodies
against REV-ERBα, HNF6 and PPARα were used to identify the
promoter sequences in Fgf21 bound by these transcription factors.
We tested the four RORE-containing regions (R1-R4) in the Fgf21
promoter for binding of REV-ERBα (Fig. 3A). We observed the
strongest binding to the R1 element (which included also the HNF6
site) with weaker binding to the R4 element and no binding to the
R2 and R3 elements. Interestingly, the binding to R1 and R4 was
time-of-day dependent with more REV-ERBα binding at ZT10 than
ZT22 (Fig. 3A), which is consistent with the expression pattern of
Fgf21 (Fig. 1D,E). The pattern of REV-ERBα binding was similar
compared to the Bmal1 and Rev-erbα promoter controls (Fig. 3A).
In contrast, binding of HNF6 to the Fgf21 promoter was not time-of-
day dependent and only occurred in the R1 element, which includes
the HNF6 binding site. R2, R3 and R4 did not show HNF6 binding
(Fig. 3B). Similar to HNF6, PPARα binding to the Fgf21 promoter
was not time-of-day dependent, with strong binding at both ZT8 and
ZT20 in both wild-type and Rev-erbα−/− mice (Fig. 3C).
Interestingly, PPARα binding to the Bmal1 promoter was time-of-
day dependent (Fig. 3C), indicating that the mechanism of
regulation by PPARα of the Fgf21 promoter is different from the
regulation of the Bmal1 promoter.
Because PER2 can bind to both REV-ERBα and PPARα
(Schmutz et al., 2010), we tested PER2 binding to the Fgf21
promoter. We observed that PER2 binds in a time-of-day dependent
manner to both the Bmal1 and Fgf21 promoters in wild-type mice,
however, only to the Bmal1 promoter in Rev-erbα−/− animals
(Fig. 3C). This indicates that binding of PER2 to the Fgf21 promoter
depends on the presence of REV-ERBα and/or PPARα.
DISCUSSION
There is strong evidence that the circadian clock influences fertility
and therefore reproductive fitness in mice (Miller and Takahashi,
2013; Sellix and Menaker, 2010). We observed that Rev-erbα−/−
mice produce less pups and have less litters associated with a longer
inter-litter period (Fig. 1A-C); however, the mechanisms linking the
clock with reproduction are not well understood. We provide
evidence that FGF21, which regulates metabolism (reviewed in
Nies et al., 2016) andmodulates fertility (Owen et al., 2013), may be
one of the links.
Animals overexpressing FGF21 show reduced fertility, which is
similar to the phenotype of Rev-erbα−/− animals. This similarity is
further highlighted by our finding that expression of Fgf21 mRNA,
as well as FGF21 protein, is elevated in Rev-erbα−/− mice
(Fig. 1D,E). Hence, Rev-erbα−/− animals can be considered as
Fgf21 overexpressors, although they overexpress Fgf21 to a much
lesser extent compared to the transgenic mice described by Owen
et al. (2013).
The diurnal cycling of Fgf21 mRNA in wild-type liver (Fig. 1D)
is similar to the diurnal expression of Bmal1, indicating that
BMAL1/CLOCK are most likely not responsible for Fgf21 cycling,
despite a previous report that described BMAL1/CLOCK-mediated
activation of a 2 kb long Fgf21::luc reporter (Tong et al., 2010). Our
own experiments indicate that our 3.1 kb Fgf21::luc reporter is not
activated by BMAL1/CLOCK (Fig. 2A). Interestingly, ChIP-
sequencing experiments revealed BMAL1 binding to the Fgf21
promoter, however no evidence of binding for CLOCK or NPAS2
was found (Koike et al., 2012). This indicates that the Fgf21
promoter is most likely not activated by BMAL1/CLOCK or
BMAL1/NPAS2 heterodimers in vivo. What the role of BMAL1
binding to the Fgf21 promoter is and whether it has activating
potential with an unknown heterodimerization partner remains to be
determined.
Because Fgf21 expression in liver is increased in Rev-erbα−/−
animals (Fig. 1D), reminiscent of the increased expression of Bmal1
(Preitner et al., 2002), we tested whether the Fgf21 promoter could
be repressed by REV-ERBα. We found that Fgf21was repressed by
REV-ERBα in a dose dependent manner, comparable to the Bmal1
promoter (Fig. 2B). This is in line with previous findings that
Fig. 3. Chromatin immunoprecipitation of REV-
ERBα, HNF6, PPARα and PER2 on the Fgf21
promoterof liver chromatin. (A) Binding of REV-ERBα
to its own promoter and to the Bmal1 and Fgf21
promoters at Zeitgeber time (ZT) 10 (black bars) and
ZT22 (white bars), respectively. (B) Binding of HNF6 to
the R1-R4 elements on the Fgf21 promoter at ZT10 and
ZT22. (C) Binding of PPARα on the Bmal1 and Fgf21
promoters in the liver of wild-type (black bars) and Rev-
erbα−/− (red bars) animals at ZT8 and ZT20. (D) Binding
of PER2 on the Bmal1 and Fgf21 promoters in the liver
of wild-type (black bars) and Rev-erbα−/− (red bars)
animals at ZT8 and ZT20. All panels: two-way ANOVA
with Bonferroni post-test, n=3, *P<0.05, ***P<0.001;
values are means±s.e.m.
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suggested repression of the Fgf21 promoter by REV-ERBα (Estall
et al., 2009). Interestingly, the reported RORE in that work (R1 in
Fig. 2) is not the only RORE involved in the regulation of the Fgf21
promoter as revealed by our mutation studies (Fig. 2C). It appears
that at least another RORE (R4 in Fig. 2) is involved in REV-ERBα-
mediated repression of the Fgf21 promoter.
If REV-ERBα regulates Fgf21 via direct binding to the RORE it
would compete with RORα for this binding site. Therefore, we
tested whether RORα induces the Fgf21::luc reporter in a dose-
dependent manner as it does for the Bmal1::luc reporter. We found
no dose-dependent action of RORα on the Fgf21 promoter, in
contrast to previous reports that suggested an involvement of RORα
in Fgf21 regulation (Wang et al., 2010). Of note is that no dose
response curve for RORα was established in that study, which may
lead to a misinterpretation of data. A recent study identified
nobiletin as an agonist of ROR nuclear receptors. Application of
nobiletin increased expression of ROR target genes in the liver
involved in metabolism, with Fgf21 being unaffected (He et al.,
2016). This supports our observation that RORα is not involved in
the regulation of Fgf21 expression in the liver. From our data we
conclude that REV-ERBα may act on the Fgf21 promoter via
another mechanism, different from the competition mechanism
between REV-ERBα and RORα.
A recent study identified a secondmode of action for REV-ERBα
in the liver. Whereas the direct competition mechanism between
REV-ERBα and ROR transcription factors provides a universal
mechanism for self-sustained control of the molecular clock across
all tissues, REV-ERBα uses lineage-determining factors to convey a
tissue-specific rhythm that regulates metabolism tailored to the
specific need of that tissue (Zhang et al., 2015). In the liver, the
tissue-specific factor is HNF6 through which REV-ERBα can
modulate gene expression in an HNF6-dependent fashion. In
accordance with this hypothesis, we found that REV-ERBα
regulates Fgf21 expression involving HNF6 (Figs 2E,F, 3B and
Fig. S1). This concept is also consistent with the observation that
REV-ERBα can regulate FGF21 signaling in an adipose tissue-
specific manner by directly regulating βKlotho, an essential co-
receptor for FGF21 signaling (Jager et al., 2016).
In addition to HNF6 binding sites (Fig. 3B), we found PPAR
elements in the Fgf21 promoter sequence (Figs 2G and 3C). We
could confirm that PPARα regulates expression of Fgf21 (Figs 2G
and 3C) as described previously (Oishi et al., 2008). Furthermore,
we observed that PER2 can increase induction of the Fgf21::luc
reporter (Fig. 2G). This increase may be partially mediated by
binding of PER2 to PPARα, but lack of REV-ERBα abolishes
binding of PER2 to the Fgf21 promoter of liver chromatin (Fig. 3D),
suggesting a complex regulation of the Fgf21 promoter by PPARα
and REV-ERBαwith PER2modulating the transcriptional potential
of both of these nuclear receptors. This is consistent with previous
observations reporting that PER2 is binding to both PPARα and
REV-ERBα (Schmutz et al., 2010). Hence, PER2 may mediate the
formation of a time-of-day dependent super complex containing
PPARα and REV-ERBα, most likely along with additional co-
factors.
Taken together, we present evidence that REV-ERBα regulates
Fgf21 expression in the liver involving HNF6. This mechanismmay
be influenced by PER2 and PPARα (Fig. 4). Since FGF21 is
released from the liver into the bloodstream to reach the brain
influencing fertility via the hypothalamus, REV-ERBα may
modulate fertility via this pathway. However, the contribution of
REV-ERBα to reproductive fitness is most likely not limited to
Fgf21 regulation, but may also include additional processes, such as
the regulation of ovarian biology and metabolic pathways known to
be regulated by REV-ERBα (Bugge et al., 2012; Cho et al., 2012),
thereby affecting fertility in an indirect manner.
MATERIALS AND METHODS
Animals
Animal care and handling were performed in accordance with the guidelines
of the Schweizer Tierschutzgesetz (TSchG, SR455) and the Declaration of
Helsinki. The protocol was approved by the state veterinarian of the Canton
of Fribourg. Rev-Erbα−/− mice were obtained from Dr U. Schibler
(University of Geneva, Switzerland) and are on a mixed background
129Sv/C57BL6 (Preitner et al., 2002). Animals were maintained on 12 h
light:12 h dark cycle with food and water ad libitum.
Cell culture and luciferase assay
NIH3T3 and Hepa-1c1c7 mouse cells were used for in vitro experiments.
Cells were maintained in Dulbecco’s Modified Eagle Medium (DMEM),
high glucose (4.5 g/l) (6429, Sigma, USA) containing 10% fetal calf serum
(FCS) and 100 U/ml penicillin/streptomycin at 37°C in a humidified
atmosphere containing 5% CO2.
Expression plasmids pSCT1-PPARα, pSCT1-RXRα, pSCT1-PER2,
pSCT1-LacZ (β-galactosidase), pSCT1-REV-ERBα, pSCT1-RORα and
Bmal1 luciferase construct (with PPAR regulatory site) are described
(Schmutz et al., 2010).
Mouse Fgf21 promoter is harboring four putative retinoid orphan receptor
elements (ROREs) and one PPAR response element (PPRE). Five different
sizes of mouse Fgf21 promoter fragments were amplified by PCR and
cloned into pGL3 basic vector (Promega, USA) using following primers:
CGGTACCCTGAAGCCCCAGGTTC (R1_sense primer, KpnI site),
GCTCGAGCCAAGGCAGCTGGAATTG (R1_anti-sense primer, XhoI
site), CGGTACCCAGGAGGATGGAGAAC (R2_sense primer, KpnI site),
GCTCGAGGAACCTGGGGCTTCAG (R2_anti-sense primer, XhoI site),
CACGCGTGTCCGGCTTAGTGAAC (R3_sense primer, MluI site),
GCTCGAGGTTCTCCATCCTCCTG (R3_anti-sense primer, XhoI site),
CACGCGTCTCCTGTCCATTGCCAG (R4_sense primer, MluI
site), GCTCGAGGTTCACTAAGCCGGAC (R4_anti-sense primer,
XhoI site), CACGCGTCAGATTAAGCCACCGAGTC (sense primer,
MluI site), GCTCGAGCTGGTGAACGCAGAAATAC (anti-sense
primer, XhoI site). Generated luciferase reporter plasmids were designated
as R1 (+133 to −918 bp), R2 (−919 to −1816 bp), R3 (−1817 to
−2892 bp), R4 (−2893 to −4133 bp) and Fgf21: luc (+2 to −3099). The
potential RORE and HNF6 binding elements were mutated by site-directed
Fig. 4. Schematic representing clock contribution to Fgf21 regulation in
the liver.REV-ERBα (R orange circle) represses the Fgf21 promoter involving
HNF6 (olive trapezoid). Furthermore, PPARα (green oval) with its
heterodimerizing partner RXR (light blue oval) activates the Fgf21 promoter.
PER2 (P2, red circle) most likely modulates one or both of these regulations
due to its capacity to bind to PPARα and REV-ERBα. Our data indicate that
BMAL1 (B blue circle) and CLOCK (C/N purple oval) are not significantly
involved in the regulation of Fgf21.
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mutagenesis using the following primers: –90 CCAAGTGGGCCCAGG-
ATCCCGGGCCCGGAGTG –47 (mut_R1), –3058 TGAGATTTTCAG-
TGGGGCCCGGAGCTATGCAAAT –3023 (mut_R4) and –117 CCTG-
GCCACGGTGGGCCCCCGGGTCCTGCCAAGTGTG –81 (mut_Hnf6).
Luciferase assays were performed in NIH3T3 cells as described (Langme-
sser et al., 2008). An empty pGL3 vector was used as negative control.
Bmal1::luc and Per1::luc reporter were used as positive controls.
Knockdown of HNF6 and western blot analysis
24 h after seeding cells, HNF6-shRNA plasmid (HNF-6 sc-37937-SH,
Santa Cruz Biotechnology, USA) was used for knocking-down of HNF6,
according to the manufacturer’s instructions. Scrambled shRNA plasmid
(sc-108060, Santa Cruz Biotechnology) was used as a negative control.
Knockdown efficiency was assessed 48 h post-transfection by western
blotting as well as by real time PCR. Protein of transfected Hepa-1c1c7 cells
was extracted using RIPA buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl,
1 mM EDTA, 0.1% SDS, 1% Triton X-100, 0.5% sodium deoxycholate
containing protease and phosphatase inhibitors). Protein samples were
subjected to electrophoresis on 10% SDS-polyacrylamide gels and
transferred to a nitrocellulose (Amersham Protran Supported 0.45 NC, GE
Healthcare). After blocking with 0.5% dry milk in PBS-Tween 0.1%, the
membranes were probed with anti-HNF6 (1:500, Santa Cruz
Biotechnology, sc-376167), and HSP90 (1:1000, Santa Cruz
Biotechnology, sc-13119) antibodies overnight at 4°C. Anti-rabbit and
-mouse HRP conjugated antibody was used as a secondary antibody.
Detection of the immune complexes was performed using WesternBright
Quantum system (Advansta, K-12042, USA) and quantification was done
with the Quantity One analysis software (Bio-Rad).
RNA extraction and qPCR
Total RNA was extracted from frozen liver using RNA-Bee (AMS
Biotechnology, CS-105B, UK). RNA samples were treated with DNase I
(Roche), and purified by phenol:chloroform extraction and ethanol
precipitation. cDNA synthesis was carried out with SuperScript II
(Invitrogen) and SYBR green based real-time PCR was performed for
mRNA quantification using KAPA SYBR FAST (KAPA Biosystems, KK-
4601, UK) and RotorGene 6000 (Corbett Research, RG-6000, Germany).
All RNA samples were normalized to Gapdh. Primers are:
Gapdh:
sense: 5′-CATGGCCTTCCGTGTTCCTA-3′
antisense: 5′-CCTGCTTCACCACCTTCT TGA-3′;
Fgf21:
sense: 5′-ACTGCTGCTGGACGGTTA-3′
antisense: 5′-GCATCCTGGTTTGGGGAGTCCTT-3′;
Rev-erbα:
sense: 5′-CAAGGCAACACCAAGAATGTT-3′
antisense: 5′-TTCCCAGATCTCCTGCACAGT-3′;
Hnf6:
sense: 5′-CCCTGGAGCAAACTCAAGTC-3′
antisense: 5′-GGTCTCTTTCCG TGCTGCTA-3′.
The values were calculated using the double delta Ct method. 81 cycles of
10 s at 55°C with increasing increments of 0.5°C per cycle was performed
for melting curve analysis. A negative control for each primer pair was
included on each plate. Melting curve analysis was performed to confirm
that only one product was amplified and there were not any products in
negative controls. LinRegPCR was used to calculate PCR efficiencies for
each sample. The RNA source, Average Ct, working annealing temperature,
the average amplification efficiency and coefficients of variation are given
for each gene in Table S1.
Chromatin immunoprecipitation
For the chromatin immunoprecipitation (ChIP) experiments, mice were
sacrificed at ZT10 and ZT22. The livers of mice were homogenized in 1×
phosphate-buffered saline supplemented with 1% formaldehyde, incubated
for 5 min at room temperature, and nuclei and chromatin prepared according
to (Schmutz et al., 2010). Briefly, pure liver nuclei form each mouse were
obtained by centrifugation through 2.05 M sucrose cushions and the
chromatin in 500 μl of 1% SDS, 20 mM Tris pH 7.4, 150 mM NaCl, and
2 mM EDTA was fragmented by sonication (10×10 s pulses at 50%
intensity using a Branson SLPe device equipped with a microtip). After a
10-fold dilution with 1.1% Triton X-100, 20 mM Tris pH 7.4, 150 mM
NaCl, and 2 mM EDTA, 200 μl of chromatin were used per reaction. DNA
fragments precipitated with anti-REV-ERBα antibody (1:50 dilution;
SAB2101632; Sigma-Aldrich), with anti-HNF6 (G-10) (1:30 dilution; sc-
376167, Santa Cruz Biotechnology), with anti-PPARα (1:25 dilution;
101710; Cayman Chemical Company, USA) or with anti-PER2 (1:25
dilution; No. 611138; BD Transduction Laboratories) were detected with
the reverse transcription PCR primers and probes enlisted in Table S2.
Along the samples, 1% of the input was processed and the % of input
calculated as precipitated material/(amount of input ×100).
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